Gene therapy startup
Nightstar has raised €39M across 1 funding round from 4 investors, most recently a Series C round in Jul 2017. Based in UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-25 | Series C | €39M |
| New Enterprise Associates,Redmile Group,Syncona Partners LLP.,Wellington Management |
| View deal → |
